Free Trial

Synthomer (SYNT) Competitors

Synthomer logo
GBX 169.60 -1.40 (-0.82%)
(As of 11:36 AM ET)

SYNT vs. VCT, ELM, ESNT, SCPA, TET, ZTF, IOF, WCH, ITX, and DCTA

Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.

Synthomer vs.

Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk.

Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 5.4%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 14.7%. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -4,098.4% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.

Victrex has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500.

Victrex currently has a consensus price target of GBX 1,425, suggesting a potential upside of 29.31%. Synthomer has a consensus price target of GBX 288.33, suggesting a potential upside of 70.01%. Given Synthomer's stronger consensus rating and higher possible upside, analysts clearly believe Synthomer is more favorable than Victrex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Victrex
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Synthomer
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Victrex£284.10M3.38£30.70M£0.353,148.57
Synthomer£1.97B0.14-£83.30M-£0.61-278.03

97.1% of Victrex shares are held by institutional investors. Comparatively, 43.8% of Synthomer shares are held by institutional investors. 1.6% of Victrex shares are held by company insiders. Comparatively, 28.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Synthomer received 219 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.49% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote.

CompanyUnderperformOutperform
VictrexOutperform Votes
507
63.61%
Underperform Votes
290
36.39%
SynthomerOutperform Votes
726
68.49%
Underperform Votes
334
31.51%

Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.33%. Victrex's return on equity of 6.36% beat Synthomer's return on equity.

Company Net Margins Return on Equity Return on Assets
Victrex10.81% 6.36% 6.59%
Synthomer -4.33%-7.90%-0.28%

In the previous week, Victrex had 8 more articles in the media than Synthomer. MarketBeat recorded 9 mentions for Victrex and 1 mentions for Synthomer. Victrex's average media sentiment score of 0.50 beat Synthomer's score of 0.00 indicating that Victrex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Victrex
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Synthomer
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Victrex and Synthomer tied by winning 10 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYNT vs. The Competition

MetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£277.42M£7.81B£2.79B£1.42B
Dividend Yield28.47%4.02%5.26%11.77%
P/E Ratio-278.03302.71120.341,573.59
Price / Sales0.14464.45947,531.63343,314.10
Price / Cash2.2818.0223.3232.92
Price / Book0.255.053.462.83
Net Income-£83.30M£133.33M£146.11M£153.14M
7 Day Performance0.59%0.96%6.46%4.35%
1 Month Performance-5.15%-3.33%7.45%19.63%
1 Year Performance-6.25%-11.09%25.41%20.36%

Synthomer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYNT
Synthomer
2.2502 of 5 stars
GBX 169.60
-0.8%
GBX 288.33
+70.0%
-5.5%£277.42M£1.97B-278.034,200News Coverage
VCT
Victrex
2.8576 of 5 stars
GBX 1,094.09
-0.2%
GBX 1,425
+30.2%
-25.8%£952.19M£284.10M3,131.431,109Dividend Increase
High Trading Volume
ELM
Elementis
N/AGBX 138.40
-0.3%
GBX 173.33
+25.2%
+16.3%£815.34M£732.20M-3,460.001,281Gap Up
ESNT
Essentra
1.9835 of 5 stars
GBX 148
+0.3%
GBX 216.67
+46.4%
-1.3%£424.97M£309.70M7,980.00350Gap Down
SCPA
Scapa Group
N/AGBX 214.50
flat
N/A+0.0%£402.98M£281.80M-7.321,461
TET
Treatt
2.3385 of 5 stars
GBX 475
flat
GBX 675
+42.1%
+13.1%£288.42M£143.55M2,638.89350Dividend Increase
News Coverage
ZTF
Zotefoams
N/AGBX 342
-3.1%
N/A+6.9%£166.21M£133.40M1,765.00549News Coverage
IOF
Iofina
2.7539 of 5 stars
GBX 19.07
+1.6%
GBX 35
+83.6%
-20.8%£36.58M£51.71M1,900.0095
WCH
Wilmcote Holdings plc (WCH.L)
N/AGBX 3
flat
N/A+0.0%£20.13MN/A-5.003
ITX
Itaconix
N/AGBX 122
-2.2%
N/A-7.9%£16.46M£6.62M-3,150.0017Gap Down
DCTA
Directa Plus
N/AGBX 8.05
flat
N/A-70.0%£8.41M£9.33M-137.50187High Trading Volume

Related Companies and Tools


This page (LON:SYNT) was last updated on 12/10/2024 by MarketBeat.com Staff
From Our Partners